The cDNA for human muscle glycogen synthase encodes a protein of 737 amino acids. The primary structure of glycogen synthase is not related either to bacterial glycogen synthase or to any glycogen phosphorylase. All nine of the serines that are phosphorylated in the rabbit muscle enzyme in vivo are conserved in the human muscle sequence. The amino-and carboxyl-terminal fragments, which contain all the phosphorylation sites, are very negatively charged. Overall the unphosphorylated protein has a charge of -13, while the fully phosphorylated inactive protein has a net charge of -31. The importance of the asymmetrical charge distribution is discussed.
of the serines that are phosphorylated in the rabbit muscle enzyme in vivo are conserved in the human muscle sequence. The amino-and carboxyl-terminal fragments, which contain all the phosphorylation sites, are very negatively charged. Overall the unphosphorylated protein has a charge of -13, while the fully phosphorylated inactive protein has a net charge of -31. The importance of the asymmetrical charge distribution is discussed.
Storage of a carbohydrate, such as glycogen, is required in virtually all cell types so that when necessary the storage carbohydrate can be degraded for energy production. Glycogen has been shown to be a remarkably uniform molecule with a diameter of 400 A, containing %=4000 chains of a-1,4-linked glucose residues (1) . Glycogen chains are on average 11-14 residues long and are branched by a-1,6 linkages. In mammals, synthesis of the unbranched glycogen chains requires uridine diphosphate glucose (UDPG) and is carried out by the enzyme glycogen synthase (UDP glucose: glycogen 4-a-D-glucosyltransferase, EC 2.4.1.11) (2) . Since the discovery of glycogen synthase, two forms of the rabbit muscle enzyme have been characterized (3) ; one form of the enzyme shows no activity except in the presence of glucose 6-phosphate, while the other is fully active in the absence of this allosteric activator. The interconversion between the two forms of glycogen synthase is dependent on specific protein kinases and protein phosphatases (4) . Currently, seven different protein kinases have been implicated in the phosphorylation of nine different sites in vivo (5) .
The reaction that is catalyzed by glycogen synthase is the transfer of the glucosyl residue from UDPG to the nonreducing end of a-1,4-glucan. In terms of physiology, this reaction can be thought of as the complement of the reaction carried out by glycogen phosphorylase, although the chemistry of the two reactions is not equivalent. Glycogen synthase and phosphorylase are also complementary in the ligands that interact with each of the enzymes (6, 7) . Glucose 6-phosphate is an inhibitor of phosphorylase activity, whereas it is an activator of synthase. UDPG is a substrate for glycogen synthase but an inhibitor of phosphorylase, and both enzymes require glycogen as a substrate. Perhaps the most striking antiparallel between glycogen synthase and phosphorylase is the opposite effect on activity of each enzyme induced by phosphorylation.
The N-terminal 43 (8, 9 ) and the C-terminal 124 (10) amino acids ofrabbit muscle glycogen synthase, containing all ofthe in vivo phosphorylation sites, have previously been determined. We undertook the cDNA cloning and sequencing of human muscle glycogen synthase to provide a context for the multiple phosphorylation sites and as a first step in determining whether the complementarity suggested by the regulation and function of glycogen synthase and phosphorylase might be represented in terms of structural similarity. The primary sequences of glycogen synthase and phosphorylase were found to be unrelated. The complete amino acid sequence of glycogen synthase reveals a striking charge asymmetry, which is likely involved in its control by multiple phosphorylation events.t
MATERIALS AND METHODS
Cloning and Sequencing of Glycogen Synthase cDNAs. A Agtl0 cDNA library was made from rabbit muscle poly(A)+ mRNA using the cDNA synthesis system from Amersham Corp. The amino acid sequence Ala-Lys-Ala-Phe-ProAsp-His-Phe-Thr-Tyr-Glu-Pro-His-Glu-Ala-Asp-Ala from the C-terminal peptide of rabbit muscle glycogen synthase (10) (12) . The complete human muscle glycogen synthase cDNA sequence was determined by doublestranded dideoxynucleotide sequencing using Sequenase (U.S. Biochemicals). The cDNA sequence information was managed and all sequence comparisons were performed with the sequence analysis software package from the University of Wisconsin, version 5.2 (13).
Blot-Hybridization Analysis. RNA samples from human fetal and adult skeletal and heart tissue and from rabbit brain and liver tissue were electrophoresed through a formaldehyde/agarose gel, transferred to nitrocellulose, and hybridized with the 2.7-kb human muscle glycogen synthase cDNA.
The filter was washed with 0.5x SSC at 550C before autoradiography. The RNA ladder from Bethesda Research Laboratories was used for size markers.
RESULTS
Blot Hybridization of Muscle, Brain, and Liver RNA. Analysis of the rabbit muscle cDNA clones showed that the deduced amino acid sequence was different from the published C-terminal phosphorylated peptide sequence (10) in two positions (amino acids 729 and 731; see Fig. 3B ). Northern blot analysis ofrabbit muscle mRNA suggested that these clones were not full length (K.N., unpublished data).
To determine the predicted size of a full-length muscle glycogen synthase cDNA, total RNA samples were isolated from both human fetal and adult heart and skeletal muscle tissue and analyzed by blot hybridization using the 2.7-kb human muscle glycogen synthase cDNA clone as a probe (Fig. 1) . A single band corresponding to an mRNA of =3.5 kb was identified in all the muscle samples, suggesting that the longest human muscle cDNA was indeed a full-length muscle glycogen synthase cDNA. From this blot hybridization, glycogen synthase mRNA seems to be most abundant in the adult skeletal muscle sample (lane AS) and is slightly more abundant in fetal heart than in fetal skeletal tissue (lanes FH and FS). This is, however, not definitive because the amount of RNA analyzed was only standardized by its absorbance at 260 nm.
When RNA samples from rabbit brain and liver were analyzed in the same manner, a single hybridizable mRNA was identified and was predicted to be =2.4 kb (Fig. 1) . Although it appears from this blot hybridization analysis that glycogen synthase mRNA is more abundant in brain than in liver, this may not be accurate since 5 jug of poly(A)+ rabbit brain mRNA was analyzed, whereas 10 ug oftotal rabbit liver RNA was used.
Human Muscle Glycogen Synthase cDNA Sequence. The complete sequence of the 3.5-kb human muscle cDNA clone was obtained by using oligonucleotide primers spaced to produce overlapping sequence fragments on both strands to nucleotide 2475; the complete cDNA sequence is shown in Fig. 2 . The 5' untranslated region is predicted to extend 160 base pairs upstream of the first in-frame ATG. The predicted amino acid sequence starting from the proline (after the first methionine) and extending for 43 amino acids is confirmed by similarity to the amino acid sequence from the N-terminal phosphorylated rabbit muscle peptide (4) and to the predicted active site peptide (8, 9) . Further confirmation ofthe deduced human muscle glycogen synthase amino acid sequence was provided by another peptide sequence obtained from active site analysis (9) and from the carboxyl-terminal amino acid sequence (10) . The stop codon is at position 2374 of the cDNA after an open reading frame that encodes 737 amino acids. The predicted molecular mass for this protein is 83,645 Da and the calculated pI is 5.8 (14) . The 3' untranslated region of this cDNA clone is 1156 base pairs. Although the polyadenylylation signal AATAAA was not found (the closest match is AAAAAA at position 3508), the correspondence in size between the cDNA and the hybridizable mRNA species confirms that this clone is full length.
The cDNA sequence for human muscle glycogen synthase shows a biased G+C content as has been observed for other muscle cDNAs (15) ; overall the G+C content is 59.0% and in the third codon position it is 77.2%. In both cases, the G+C content of human muscle glycogen synthase was found to be slightly below average when compared to other muscle cDNAs but well above the average G+C content reported for various liver isozyme cDNAs. The relatively high G+C content of human muscle glycogen synthase is also observed in the 5' untranslated region (67.5%). The (19) .
Comparison of Human and Rabbit Glycogen Synthase Phosphorylation Sites. The amino acid sequence deduced for human muscle glycogen synthase was compared to the amino acid sequence for the N-and C-terminal phosphorylation peptides from rabbit muscle glycogen synthase (Fig. 3) . The N-terminal peptide from rabbit muscle (8, 9) corresponds to the N-terminal sequence from the human muscle cDNA except for the initiating methionine and three substitutions (Fig. 3A) . Two of the substitutions are conservative, but the third amino acid, which is a serine in the rabbit muscle peptide, is an asparagine in the human sequence, a semiconservative substitution. Overall, however, there is 95% similarity between the human and rabbit sequences in this region.
The 124-amino acid C terminus from rabbit muscle glycogen synthase (10), which is thought to contain the majority of the phosphorylation sites, is 94% similar to the corresponding region in human muscle glycogen synthase (Fig. 3B) . The cDNA-derived rabbit muscle C-terminal sequence shows greater identity to the human sequence than the proteinderived sequence. The amino acid sequences surrounding phosphorylation sites la, 3a, -b, and -c, and 5 are absolutely conserved between rabbit and human glycogen synthase. However, to align the human and rabbit sequences around phosphorylation site lb, it is necessary to gap both sequences once. A serine N-terminal of the phosphorylation site in the rabbit peptide is not present in the human sequence, and there is a 3-amino acid insertion in the human sequence C-terminal of the phosphorylated serine.
N-terminal and C-terminal peptide sequences, corresponding to phosphorylation sites 2 and 3a, -b, and -c in muscle, have been determined for rabbit liver giycogen synthase (20) . The similarity between both liver peptides and either the rabbit or human sequence is 76% (Fig. 3) . ated residues is given.
same based on the size of mRNA species that were hybridized. The mRNA species in rabbit brain and liver tissue that hybridized to the human muscle glycogen synthase cDNA is :1.0 kb smaller than the mRNA expressed in the human muscle tissues. Previous evidence for a liver glycogen synthase isozyme comes both from immunological studies and from analysis of phosphorylated peptides from glycogen synthase purified from liver tissue (20) . The apparent molecular mass of the dephosphorylated form of rabbit liver glycogen synthase has been reported to be 86 kDa, approximately the same as the muscle isozyme (21) . An mRNA 1.0 kb smaller than the muscle mRNA could encode a protein ofthe same size since the 3' untranslated region of the muscle cDNA is 1.2 kb. In a conflicting report, the rat liver glycogen synthase protein was reported to be 93 kDa (22) . It is very unlikely that a 2.4-kb mRNA could encode a protein of this size. The data from the blot hybridization analysis lead us to suggest that the liver isozyme will also be present in the brain. Previously, it has been suggested from immunological studies that the muscle isozyme was present in brain and that the liver isozyme was only found in liver tissue (23) . Bacterial glycogen synthase and human muscle glycogen synthase are not homologous. Sequence comparisons of human muscle glycogen synthase and the proteins reported to be responsible for glycogen synthesis in Escherichia coli (16, 17) found no similarity between the primary amino acid sequences. In contrast, mammalian and bacterial glycogen phosphorylase share 54% identity of amino acid residues in the catalytic domain of the protein and almost 34% identity in the regulatory domain (24, 25) . The mammalian and bacterial synthase enzymes differ, however, in their glucose substrates; mammalian glycogen synthase requires UDPG and other glucosyl donors are used only inefficiently (reviewed in ref. 26) , whereas bacterial synthase requires ADP-glucose as a substrate. Furthermore, in bacteria the synthesis of ADP-glucose is the regulated step and the allosteric effectors of mammalian glycogen synthase (phosphorylation and glucose 6-phosphate) do not affect bacterial glycogen synthesis (27) . In light of the lack of similarity between the primary sequence of mammalian and bacterial glycogen synthases, it is noteworthy that only 90% identity between closely related bacterial glycogen synthase sequences is found (17) , suggesting that glycogen synthase is a rapidly evolving enzyme.
In general, physiologically complementary enzyme pairs are not expected to be homologous since the synthetic and degradative reactions they catalyze are not chemically the 35 35 61 620 N reverse of each other. In the case of glycogen synthase and phosphorylase, however, many of the same ligands regulate the two molecules. Therefore, it is somewhat surprising that the primary amino acid sequence of glycogen synthase is not similar to glycogen phosphorylase. A comparison of the 56 amino acids that compose the glycogen-binding region of phosphorylase (28) with the glycogen synthase amino acid sequence reveals no primary sequence similarity. Sequence comparisons between glycogen synthase and other sugarbinding proteins likewise reveal no primary sequence similarities. This lack of similarity between glycogen synthase and other sugar-binding molecules may be explained by several of the unique features known about the synthaseglycogen interaction. It has been established that glycogen synthase requires a protein-primed glycogen molecule (29, 30) and that glycogen synthase adds glucose to the end of several hundreds of glycogen chains before dissociation from the glycogen molecule (31) . Furthermore, glycogen synthase binds glycogen more strongly relative to other glycogenbinding molecules (26) . A striking feature of the glycogen synthase amino acid sequence is the asymmetrical distribution of negative charge. Overall, the unphosphorylated protein has a charge of -13 without the additional positive charges of the 18 histidine residues at pH 6.0 or the N-and C-terminal charges, while the fully phosphorylated protein would have an overall negative charge of -31 (Fig. 4) . The negative charges are concentrated at the N (9 of the 35 N-terminal amino acids) and C termini (24 of the 117 C-terminal amino acids). The remaining core of the protein has a net charge of +3, which is similar to other glycolytic enzymes. The asymmetric configuration of negative charges probably has a functional role given that the two negatively charged domains contain all nine phosphorylation sites used in vivo; 2 senine residues are phosphorylated at the N terminus and 7 C-terminal seine residues are phosphorylated (5), thus increasing the overall negative charge of these regions. Five of the negative charges in the C-terminal region are conserved as part of the primary recognition site for casein kinase 2 (32) .
The C-terminal region of glycogen synthase is also unusual in that there are very few hydrophobic amino acids (9%) in the region that is highly charged. The rest of the protein contains a more typical distribution of hydrophobic amino acids (31%). Because of the extreme hydrophilic and charged nature of the C-terminal region, it has been speculated that this region is poorly ordered in the protein structure (33 This highly charged region of the protein is most likely involved in interactions within the quaternary structure, with other proteins in the glycogen particle such as glycogenin or with the glycogen molecule. We favor the hypothesis that the negatively charged C-terminal region interacts with glycogen; this hypothesis is supported by the finding that under certain physiological conditions glycogen inhibits the rate at which glycogen synthase may be dephosphorylated (34) . This inhibition of dephosphorylation could occur by the direct interaction of glycogen with this region or by a structural change in the C-terminal domain when glycogen is bound elsewhere in the molecule. Perhaps the negatively charged regions that are being identified in many diverse proteins will be found to have common structural roles in protein-protein or in other intermolecular interactions.
All nine of the in vivo phosphorylated serines in rabbit muscle glycogen synthase are conserved in the human muscle glycogen synthase sequence. Serine N-3 in rabbit muscle, which is phosphorylated in vitro but not in vivo by casein kinase 1, is not conserved in the human sequence, which supports the conclusion that this phosphorylation event is not functionally important (5) . Although the most C-terminal serine that is phosphorylated in rabbit muscle (lb) is conserved in the human sequence, the surrounding sequence of this phosphorylation site is relatively divergent; the alignment between the rabbit and human sequence in this region suggests that there has been an insertion/deletion event in the evolution of the two proteins. The rate of phosphorylation of this site has been shown to be significantly slower than for the other serines, which are phosphorylated by cyclic-AMPdependent protein kinase, and may therefore be less important for the regulation of glycogen synthase activity in vivo (4). Glycogen synthase does not have to be fully phosphorylated to be inactive; different phosphorylation sites are probably used in response to different physiological stimuli. In the C-terminal region, phosphorylation of two serines has been shown not to change the activity of the enzyme, but rather to sequentially create the recognition site for future phosphorylation, which leads to a change in enzyme activity (35) . It is of interest to determine whether the inactivation of glycogen synthase by phosphorylation involves a conformational change or whether perhaps the protein is inactivated due to the increase in local negative charge. Structural studies have shown that ordering of N-terminal residues is involved in the activation of glycogen phosphorylase by phosphorylation (36) and the phosphorylation of the N-terminal serines of glycogen synthase may be similar. Phosphorylation of the C-terminal region of glycogen synthase, however, likely involves structural changes since as many as 14 negative charges must be incorporated into the protein structure.
In addition to the intriguing structural features of the enzyme that were revealed by the sequence of the cDNA clone, we are now in a position to use molecular approaches to determine the role of the different phosphorylation sites in regulating glycogen synthase activity and by doing so obtain a better understanding of the functional role of the observed charge asymmetry.
